Header Logo

Connection

AYSE MINDIKOGLU to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
AYSE MINDIKOGLU
Connection Strength
0.066
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Imatinib mesylate (gleevec) hepatotoxicity. Dig Dis Sci. 2007 Feb; 52(2):598-601.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.